Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ginell Post

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPathology, College of Medicine
DivisionPathology Clinical
AddressB.032 Hospital (new hospital)
4200 Shuffield.
Mail Slot # 502
Little Rock AR 72205
Phone501-526-6776
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My current clinical and research interests are in the area of hematopathology with focus on cancer- and inflammation-related coagulopathies and use molecular-genetic and immunohistochemical approaches to classify and understand the pathobiology of hematopoietic diseases.


    Collapse Affiliation 
    Collapse member of
    American Society of Clinical Pathologists (ASCP)
    Association of Clinical Scientists (ACS)
    College of American Pathologists (CAP)
    Collapse clinical activities
    Hematopathologist: Bone marrow, lymph node, flow cytometry and peripheral blood/body fluid review
    Director Special Coagulation: Thrombosis panels, Lupus anticoagulant panels, mixing studies, factor assays, platelet function, ELISA, ROTEM and clinical consults

    Collapse Biography 
    Collapse Leadership and Administrative Roles
    Director, Hematopathology Fellowship
    Co-Director, Division of Hematopathology


    Collapse Research 
    Collapse research activities and funding
    1P20GM139768     (RACINE MIOUSSE, ISABELLE)Apr 1, 2021 - Feb 28, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: University of Arkansas at Fayetteville
    Methionine restriction as an adjuvant therapy in melanoma
    Role: Principal Investigator
    1P20GM139768-01     (RACINE MIOUSSE, ISABELLE)Apr 1, 2021 - Feb 28, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: University of Arkansas at Fayetteville
    Methionine restriction as an adjuvant therapy in melanoma
    Role: Principal Investigator
    5P20GM139768     (RACINE MIOUSSE, ISABELLE)Apr 1, 2021 - Feb 28, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: University of Arkansas at Fayetteville
    Methionine restriction as an adjuvant therapy in melanoma
    Role: Principal Investigator
    5P20GM139768-02     (RACINE MIOUSSE, ISABELLE)Apr 1, 2021 - Feb 28, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: University of Arkansas at Fayetteville
    Methionine restriction as an adjuvant therapy in melanoma
    Role: Principal Investigator
    5P20GM139768-03     (RACINE MIOUSSE, ISABELLE)Apr 1, 2021 - Feb 28, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: University of Arkansas at Fayetteville
    Methionine restriction as an adjuvant therapy in melanoma
    Role: Principal Investigator
    5P20GM139768-04     (RACINE MIOUSSE, ISABELLE)Apr 1, 2021 - Feb 28, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: University of Arkansas at Fayetteville
    Methionine restriction as an adjuvant therapy in melanoma
    Role: Principal Investigator
    5P20GM139768-05     (RACINE MIOUSSE, ISABELLE)Apr 1, 2021 - Feb 28, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: University of Arkansas at Fayetteville
    Methionine restriction as an adjuvant therapy in melanoma
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. McCrury M, Swafford K, Shuttleworth SL, Mehdi SH, Acharya B, Saha D, Naceanceno K, Byrum SD, Storey AJ, Xu YZ, Doshier C, Patel V, Post GR, De Loose A, Rodriguez A, Shultz LD, Zhan F, Yoon D, Frett B, Kendrick S. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma. Mol Cancer Ther. 2024 Mar 04; 23(3):316-329. PMID: 37816504.
      View in: PubMed
    2. Holloway KD, Amisha F, Post G, Goraya H. Hairy Cell Leukemia (HCL) Presenting As Severe Acute Respiratory Distress Syndrome (ARDS) With Legionella pneumophila: Coincidence or Causation? Cureus. 2023 Nov; 15(11):e48317. PMID: 38058334.
      View in: PubMed
    3. Mashayekhi A, Quiroga EF, Margolick JF, Post GR. Intestinal T-cell lymphoma: A rare entity presenting with severe acute upper quadrant pain. Clin Case Rep. 2022 Mar; 10(3):e05546. PMID: 35280095.
      View in: PubMed
    4. Xu Y, Zhou H, Post G, Zan H, Casali P. Rad52 mediates class-switch DNA recombination to IgD. Nat Commun. 2022 02 21; 13(1):980. PMID: 35190531.
      View in: PubMed
    5. Makhoul I, Ibrahim SM, Abu-Rmaileh M, Jousheghany F, Siegel ER, Rogers LJ, Lee JJ, Pina-Oviedo S, Post GR, Beck JT, Kieber-Emmons T, Monzavi-Karbassi B. P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses. Oncotarget. 2021 Oct 26; 12(22):2252-2265. PMID: 34733416.
      View in: PubMed
    6. Albayati ZAF, Penthala NR, Bommagani S, Post GR, Smeltzer MS, Crooks PA. Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone. Toxicol Rep. 2021; 8:359-364. PMID: 33665133.
      View in: PubMed
    7. Post GR, Yuan Y, Holthoff ER, Quick CM, Post SR. Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment. PLoS One. 2019; 14(11):e0224621. PMID: 31714922.
      View in: PubMed
    8. Pandey S, Gokden M, Kazemi NJ, Post GR. Hematolymphoid Malignancies Presenting with Spinal Epidural Mass and Spinal Cord Compression: A Case Series with Rare Entities. Ann Clin Lab Sci. 2019 Nov; 49(6):818-828. PMID: 31882434.
      View in: PubMed
    9. Murray GP, Post SR, Post GR. ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells. J Clin Pathol. 2020 Jun; 73(6):347-349. PMID: 31662441.
      View in: PubMed
    10. Gralewski J, Post GR. Cutaneous intralymphatic CD30+ pseudolymphoma: a reactive condition mimicking lymphoma. Blood. 2018 10 25; 132(17):1859. PMID: 30361464.
      View in: PubMed
    11. Post SR, Post GR, Nikolic D, Owens R, Insuasti-Beltran G. Development of an unbiased, semi-automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates. Cytometry B Clin Cytom. 2018 09; 94(5):602-610. PMID: 29573142.
      View in: PubMed
    12. Gralewski JH, Post GR, van Rhee F, Yuan Y. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing. Diagn Pathol. 2018 Feb 20; 13(1):15. PMID: 29463311.
      View in: PubMed
    13. Russ A, Rjoop A, Levy RA, Arthur C, Post GR. A Female Infant With Vomiting and Failure to Thrive. Clin Pediatr (Phila). 2018 07; 57(8):1004-1007. PMID: 29090599.
      View in: PubMed
    14. Post GR, Guillory E, Wade CL, LeSourd SE, Post SR. Effect of Serum Immunoglobulins on Routine Coagulation Tests: A Comparison of Coagulation Analyzers using Mechanical and Optical Clot Detection. Ann Clin Lab Sci. 2017 Nov; 47(6):744-746. PMID: 29263049.
      View in: PubMed
    15. Schinke C, Hoering A, Wang H, Carlton V, Thanandrarajan S, Deshpande S, Patel P, Molnar G, Susanibar S, Mohan M, Mathur P, Radhakrishnan M, Hoque S, Jo Kamimoto J, Grazziutti M, van Rhee F, Zangari M, Insuasti-Beltran G, Alapat D, Post G, Yaccoby S, Epstein J, Rasche L, Johnson S, Moorhead M, Willis T, Barlogie B, Walker B, Weinhold N, Davies FE, Morgan GJ. The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype. Haematologica. 2017 08; 102(8):e313-e316. PMID: 28522572.
      View in: PubMed
    16. Post GR, Bell RC, Rjoop A, Lobo RH, Yuan Y, Post SR. Diagnostic Utility of Interleukin-6 Expression by Immunohistochemistry in Differentiating Castleman Disease Subtypes and Reactive Lymphadenopathies. Ann Clin Lab Sci. 2016 Sep; 46(5):474-9. PMID: 27650613.
      View in: PubMed
    17. Singh ZN, Jethava Y, Post GR, Alapat D, Sawyer J, Waheed S, Nair B, Usmani SZ, Bailey C, Petty N, Van Rhee F, Barlogie B. Fulminant onset of acute leukemia from normal hematopoiesis within 3?months of follow up for multiple myeloma treated with total therapy protocols. Clin Case Rep. 2015 Mar; 3(3):183-92. PMID: 25838910.
      View in: PubMed
    18. Alapat DV, Ramos JM, Anderson J, Post GR. The utility of B-cell receptor gene rearrangement studies in diagnosing diffuse large B-cell lymphoma with plasmacytic differentiation. Ann Clin Lab Sci. 2015; 45(1):79-82. PMID: 25696015.
      View in: PubMed
    19. Parajuli S, Achanta L, Hopkins RH, Post G. Neutrophilic leukemoid reaction in a patient with high grade sarcoma. J Ark Med Soc. 2014 Sep; 111(4):66-7. PMID: 25255689.
      View in: PubMed
    20. Beenken KE, Mrak LN, Zielinska AK, Atwood DN, Loughran AJ, Griffin LM, Matthews KA, Anthony AM, Spencer HJ, Skinner RA, Post GR, Lee CY, Smeltzer MS. Impact of the functional status of saeRS on in vivo phenotypes of Staphylococcus aureus sarA mutants. Mol Microbiol. 2014 Jun; 92(6):1299-312. PMID: 24779437.
      View in: PubMed
    21. Scotland RL, Allen L, Hennings LJ, Post GR, Post SR. The ral exchange factor rgl2 promotes cardiomyocyte survival and inhibits cardiac fibrosis. PLoS One. 2013; 8(9):e73599. PMID: 24069211.
      View in: PubMed
    22. Zielinska AK, Beenken KE, Mrak LN, Spencer HJ, Post GR, Skinner RA, Tackett AJ, Horswill AR, Smeltzer MS. sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. Mol Microbiol. 2012 Dec; 86(5):1183-96. PMID: 23075270.
      View in: PubMed
    23. Post GR, James L, Alapat D, Guillory V, Cottler-Fox M, Nakagawa M. A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange. Transfus Apher Sci. 2013 Feb; 48(1):35-8. PMID: 22842111.
      View in: PubMed
    24. Post GR, Lazarchick J, Singh ZN. Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case. Lab Hematol. 2012 Jun; 18(2):11-3. PMID: 22709788.
      View in: PubMed
    25. Post GR, Lewis JA, Hudspeth MP, Caplan MJ, Lazarchick J. Disseminated neuroendocrine carcinoma in a pediatric patient: a rare case and diagnostic challenge. J Pediatr Hematol Oncol. 2012 Apr; 34(3):200-3. PMID: 22134610.
      View in: PubMed
    26. Post GR, Escoto H, Kalpatthi R, Lazarchick J. Osseous Hodgkin lymphoma: a rare presentation and diagnostic challenge. J Pediatr Hematol Oncol. 2011 Jul; 33(5):399-400. PMID: 20523245.
      View in: PubMed
    27. Singh ZN, Post GR, Kiwan E, Maddox AM. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature. Clin Lymphoma Myeloma Leuk. 2011 Jun; 11(3):293-7. PMID: 21658659.
      View in: PubMed
    28. Post GR, Black JS, Cortes GY, Pollack RB, Wolff DJ, Lazarchick J. The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant. Ann Clin Lab Sci. 2011; 41(2):188-92. PMID: 21844579.
      View in: PubMed
    29. Gizard F, Heywood EB, Findeisen HM, Zhao Y, Jones KL, Cudejko C, Post GR, Staels B, Bruemmer D. Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophages. Arterioscler Thromb Vasc Biol. 2011 Feb; 31(2):245-52. PMID: 21106948.
      View in: PubMed
    30. Veeraputhiran M, Ware J, Dent J, Bornhorst J, Post G, Cottler-Fox M, Pesek G, Theus J, Nakagawa M. A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal. Transfusion. 2011 May; 51(5):1030-6. PMID: 20946201.
      View in: PubMed
    31. Desouki MM, Post GR, Cherry D, Lazarchick J. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Clin Med Res. 2010 Jul; 8(2):84-8. PMID: 20660931.
      View in: PubMed
    32. Post GR, Holloman D, Christiansen L, Smith J, Stuart R, Lazarchick J. Translocation t(3;8;9)(p25;p21;q34) in a patient with features of 8p11 myeloproliferative syndrome: a unique case and review of the literature. Leuk Res. 2010 Nov; 34(11):1543-4. PMID: 20541805.
      View in: PubMed
    33. Alapat, D, Post, Singh, Z. Role of EBV expression in diagnosis of plasmablastic plasma cell myeloma. USCAP. 2010.
    34. Desouki, MM, Post, Cherry, D, Lazarchick, J. A valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Ann Clin Lab Med. 2010.
    35. Angotti LB, Post GR, Robinson NS, Lewis JA, Hudspeth MP, Lazarchick J. Pancytopenia with myelodysplasia due to copper deficiency. Pediatr Blood Cancer. 2008 Nov; 51(5):693-5. PMID: 18623212.
      View in: PubMed
    36. Gudena V, Verma N, Post G, Kizziah M, Fenning R, Montero AJ. Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review. Cancer Biol Ther. 2008 Jun; 7(6):810-3. PMID: 18376142.
      View in: PubMed
    37. Lazarchick, J, Post, GR. Hemolytic disease of the newborn secondary to ABO incompatibility. 2008.
    38. Emerick, KR, Lazarchick, J, Post, GR, Jacobson, M, Metcalf, JS. Aleukemia cutis as an initial presentation of precursor of B-cell ALL in a 3 month old. 2007.
    39. Wetzel, D, Post, GR, Lodder, RA. Synchrotron infrared microscopic analysis of collagens 1, 111 and elastin on the shoulders of human thin-cap atheroma. Vibrational Spectroscopy. 2005; (38):53-59.
    40. Chalothorn D, McCune DF, Edelmann SE, Tobita K, Keller BB, Lasley RD, Perez DM, Tanoue A, Tsujimoto G, Post GR, Piascik MT. Differential cardiovascular regulatory activities of the alpha 1B- and alpha 1D-adrenoceptor subtypes. J Pharmacol Exp Ther. 2003 Jun; 305(3):1045-53. PMID: 12649302.
      View in: PubMed
    41. Pham TM, Morris JB, Arthur JF, Post GR, Brown JH, Woodcock EA. UTP but not ATP causes hypertrophic growth in neonatal rat cardiomyocytes. J Mol Cell Cardiol. 2003 Mar; 35(3):287-92. PMID: 12676543.
      View in: PubMed
    42. Waldrop BA, Mastalerz D, Piascik MT, Post GR. alpha(1B)- and alpha(1D)-Adrenergic receptors exhibit different requirements for agonist and mitogen-activated protein kinase activation to regulate growth responses in rat 1 fibroblasts. J Pharmacol Exp Ther. 2002 Jan; 300(1):83-90. PMID: 11752101.
      View in: PubMed
    43. Post, GR, Collins, LR, Kennedy, ED, Moskowitz, SA, Aragay, AM, Goldstein, D, Brown, JH. Coupling of the thrombin receptor to G12 may account for the selective effects of thrombin on gene expression and DNA synthesis in 1321N1 cells. Mol Biol Cell. 1996; 7(1679-1690):1679-1690.
    44. Dawson, G, Dawson, S, Post, GR. Regulation of phospholipase D activity in a human oligodendroglioma cell line (HOG). J Neurosci. 1993; (34):324-330.
    45. Post, GR, Dawson, G. Characterization of a cell line derived from a human oligodendroglioma. Mol Chem Neuropathol. 1992; 16(3):303-317.
    46. Post, GR, Dawson, G. Regulation of carbachol- and histamine- induced inositol phospholipid hydrolysis in a human oligodendroglioma. Glia. 1992; 2:122-130.
    47. Thompson, R, Gibbs, RB, Post, GR, Cotman, CW, Yu, J. Lack of correlation between cortical levels of choline acetyltransferase and learning scores in rats with globus pallidus lesions. Brain Res. 1986; (387):402-404.
    48. Thompson, R, Gibbs, RB, Post, GR, Cotman, CW, Yu, J. Learning deficits in rats with early neurotoxic lesions to the globus pallidus, a substantia nigra, median raphe or pontine retucluar formation. Phys Behav. 1986; (37):141-151.
    Post's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (238) concept(s)
    _
    Co-Authors Expand Description
    See all (36) people
    _
    Similar People Expand Description
    See all (29) people
    _
    Same Department Expand Description
    Search Department